Cargando…

Transmitted/Founder Hepatitis C Viruses Induce Cell-Type- and Genotype-Specific Differences in Innate Signaling within the Liver

Hepatitis C virus (HCV) infection leads to persistence in the majority of cases despite triggering complex innate immune responses within the liver. Although hepatocytes are the preferred site for HCV replication, nonparenchymal cells (NPCs) can also contribute to antiviral immunity. Recent innovati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mitchell, Angela M., Stone, Amy E. L., Cheng, Linling, Ballinger, Kimberly, Edwards, Michael G., Stoddard, Mark, Li, Hui, Golden-Mason, Lucy, Shaw, George M., Khetani, Salman, Rosen, Hugo R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Microbiology 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357998/ https://www.ncbi.nlm.nih.gov/pubmed/25714713 http://dx.doi.org/10.1128/mBio.02510-14

Ejemplares similares

Identification, Molecular Cloning, and Analysis of Full-Length Hepatitis C Virus Transmitted/Founder Genotypes 1, 3, and 4
por: Stoddard, Mark B., et al.
Publicado: (2015)

Extracellular HCV-Core Protein Induces an Immature Regulatory Phenotype in NK Cells: Implications for Outcome of Acute Infection
por: Golden-Mason, Lucy, et al.
Publicado: (2014)

Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes
por: Davidson, Matthew D., et al.
Publicado: (2016)

Hepatitis C Virus Pathogen Associated Molecular Pattern (PAMP) Triggers Production of Lambda-Interferons by Human Plasmacytoid Dendritic Cells
por: Stone, Amy E. L., et al.
Publicado: (2013)

Correction: Hepatitis C Virus Pathogen Associated Molecular Pattern (PAMP) Triggers Production of Lambda-Interferons by Human Plasmacytoid Dendritic Cells
por: Stone, Amy E. L., et al.
Publicado: (2013)

Innate Immune Function in Placenta and Cord Blood of Hepatitis C – Seropositive Mother-Infant Dyads
por: Waasdorp Hurtado, Christine, et al.
Publicado: (2010)

Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction
por: Foster, Toshana L., et al.
Publicado: (2016)

Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques
por: Bauer, Anya, et al.
Publicado: (2023)

Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted/founder genome
por: Song, Hongshuo, et al.
Publicado: (2012)

A sequestered fusion peptide in the structure of an HIV-1 transmitted founder envelope trimer
por: Ananthaswamy, Neeti, et al.
Publicado: (2019)

Negative and Positive Selection Pressure During Sexual Transmission of Transmitted Founder HIV-1
por: Nijmeijer, Bernadien M., et al.
Publicado: (2019)

HIV-1 subtype C transmitted founders modulate dendritic cell inflammatory responses
por: Lumngwena, Evelyn Ngwa, et al.
Publicado: (2020)

Identification of early-induced broadly neutralizing activities against transmitted founder HIV strains
por: Lucas, Julie, et al.
Publicado: (2023)

The toxins of vertically transmitted Spiroplasma
por: Moore, Logan D., et al.
Publicado: (2023)

The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection
por: Goonetilleke, Nilu, et al.
Publicado: (2009)

Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes
por: O’Brien, Sean P., et al.
Publicado: (2019)

Sexually-Transmitted/Founder HIV-1 Cannot Be Directly Predicted from Plasma or PBMC-Derived Viral Quasispecies in the Transmitting Partner
por: Frange, Pierre, et al.
Publicado: (2013)

Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
por: Salazar-Gonzalez, Jesus F., et al.
Publicado: (2009)

Early and late changes in natural killer cells in response to ledipasvir/sofosbuvir treatment
por: Golden‐Mason, Lucy, et al.
Publicado: (2018)

A deeper view of transmitted/founder viruses using 454 whole genome deep sequencing
por: Tully, DC, et al.
Publicado: (2012)

Use of Dried Blood Spots to Elucidate Full-Length Transmitted/Founder HIV-1 Genomes
por: Salazar-Gonzalez, Jesus F., et al.
Publicado: (2016)

In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha
por: Ashok kumar, Manickam, et al.
Publicado: (2020)

Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction
por: Hertoghs, Nina, et al.
Publicado: (2019)

Generation and characterization of infectious molecular clones of transmitted/founder HIV-1 subtype C viruses
por: Luthuli, Bonisile, et al.
Publicado: (2023)

Foundered
por: Hayes, P. H.
Publicado: (1876)

Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants
por: Martinez, David R., et al.
Publicado: (2020)

Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted / founder sensitivity to broadly neutralizing antibodies
por: Ratnapriya, Sneha, et al.
Publicado: (2023)

Prostate cancer screening based on genotyping for high risk founder alleles
por: Cybulski, Cezary, et al.
Publicado: (2012)

Hepatitis C Virus Core Protein Inhibits Interferon Production by a Human Plasmacytoid Dendritic Cell Line and Dysregulates Interferon Regulatory Factor-7 and Signal Transducer and Activator of Transcription (STAT) 1 Protein Expression
por: Stone, Amy E. L., et al.
Publicado: (2014)

Founder cell configuration drives competitive outcome within colony biofilms
por: Eigentler, Lukas, et al.
Publicado: (2022)

Rectal Transmission of Transmitted/Founder HIV-1 Is Efficiently Prevented by Topical 1% Tenofovir in BLT Humanized Mice
por: Chateau, Morgan L., et al.
Publicado: (2013)

HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site
por: McCurley, Nathanael P., et al.
Publicado: (2017)

Infant transmitted/founder HIV-1 viruses from peripartum transmission are neutralization resistant to paired maternal plasma
por: Kumar, Amit, et al.
Publicado: (2018)

Publisher Correction: In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha
por: Ashokkumar, Manickam, et al.
Publicado: (2020)

HIV-1 Envelope Glycoprotein Amino Acids Signatures Associated with Clade B Transmitted/Founder and Recent Viruses
por: Kafando, Alexis, et al.
Publicado: (2019)

Transmitted/founder SHIV.D replicates in the brain, causes neuropathogenesis, and persists on combination antiretroviral therapy in rhesus macaques
por: Podgorski, Rachel M., et al.
Publicado: (2023)

Founder mutations and genotype-phenotype correlations in Meckel-Gruber syndrome and associated ciliopathies
por: Szymanska, Katarzyna, et al.
Publicado: (2012)

Assessing the compatibility of primary human hepatocyte culture within porous silk sponges
por: Kukla, David A., et al.
Publicado: (2020)

The Founders of Neurology
por: Lewis, P. D.
Publicado: (1972)

Inflammasomes and Their Role in Innate Immunity of Sexually Transmitted Infections
por: Verma, Vivek, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6e7912cfusaju38vim3elrfrp1